Publications

• Enrichment of IGF-1R and PPARγ signalling pathways in orbital inflammatory diseases: steps toward understanding pathogenesis.

  (Verma R, Choi D, Chen AJ, Harrington CA, Wilson DJ, Grossniklaus HE, Dailey RA, Ng J, Steele EA, Planck SR, Korn BS, Kikkawa D, Czyz CN, Foster JA, Kazim M, Harris GJ, Edward DP, Al-Hussain H, Maktabi AMY, Alabiad C, Garcia A, Rosenbaum JT.) Br J Ophthalmol. 2022 Jul;106(7):1012-1017 PMID: 33637620 02/28/2021

• Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study.

  (Douglas RS, Kahaly GJ, Ugradar S, Elflein H, Ponto KA, Fowler BT, Dailey R, Harris GJ, Schiffman J, Tang R, Wester S, Jain AP, Marcocci C, Marinò M, Antonelli A, Eckstein A, Führer-Sakel D, Salvi M, Sile S, Francis-Sedlak M, Holt RJ, Smith TJ.) Ophthalmology. 2022 04;129(4):438-449 PMID: 34688699 SCOPUS ID: 2-s2.0-85120353489 10/25/2021

• Management of periocular cutaneous squamous cell carcinoma with perineural invasion: a case series and literature review.

  (Clark TJE, Harris GJ.) Orbit. 2022 Feb;41(1):34-43 PMID: 33663321 SCOPUS ID: 2-s2.0-85123969060 03/06/2021

• Teprotumumab in Clinical Practice: Recommendations and Considerations From the OPTIC Trial Investigators.

  (Douglas RS, Wang Y, Dailey RA, Harris GJ, Wester ST, Schiffman JS, Tang RA, Fowler B, Fleming J, Smith TJ.) J Neuroophthalmol. 2021 12 01;41(4):461-468 PMID: 33417417 PMCID: PMC8584196 SCOPUS ID: 2-s2.0-85107419276 01/09/2021

• Evaluation and Medical Management of the Pediatric Patient With Orbital Cellulitis/Abscess: A Systematic Review.

  (Burek AG, Melamed S, Liljestrom T, Qi J, Kelly TG, Suelzer E, Mitchell M, Harris GJ, Havens PL.) J Hosp Med. 2021 11;16(11):680-687 PMID: 34730499 SCOPUS ID: 2-s2.0-85121956444 11/04/2021

• Case Report: Idiopathic Sclerosing Orbital Inflammation.

  (Bachman Groth JA, Harris GJ.) Optom Vis Sci. 2021 04 01;98(4):409-417 PMID: 33852556 SCOPUS ID: 2-s2.0-85104462311 04/15/2021

• Fate and Management of Incompletely Excised Solitary Fibrous Tumor of the Orbit: A Case Series and Literature Review.

  (Jackson CH, Hunt BC, Harris GJ.) Ophthalmic Plast Reconstr Surg. 2021 Mar-Apr 01;37(2):108-117 PMID: 32496393 SCOPUS ID: 2-s2.0-85095782958 06/05/2020

• The spectrum of orbital dermoid cysts and their surgical management.

  (Bajric J, Harris GJ.) Orbit. 2020 Aug;39(4):266-275 PMID: 31246146 SCOPUS ID: 2-s2.0-85068150213 06/28/2019

• Teprotumumab for the Treatment of Active Thyroid Eye Disease.

  (Douglas RS, Kahaly GJ, Patel A, Sile S, Thompson EHZ, Perdok R, Fleming JC, Fowler BT, Marcocci C, Marinò M, Antonelli A, Dailey R, Harris GJ, Eckstein A, Schiffman J, Tang R, Nelson C, Salvi M, Wester S, Sherman JW, Vescio T, Holt RJ, Smith TJ.) N Engl J Med. 2020 01 23;382(4):341-352 PMID: 31971679 SCOPUS ID: 2-s2.0-85078308444 01/24/2020

• Surgical Management of a Recurrent Odontogenic Keratocyst With Orbital and Temporal Fossa Invasion.

  (Brookes CCD, Harris GJ.) Ophthalmic Plast Reconstr Surg. 2019 Nov/Dec;35(6):e151-e154 PMID: 31693641 SCOPUS ID: 2-s2.0-85074625867 11/07/2019

• Surgical Timing for Congenital Ptosis Should Not Be Determined Solely by the Presence of Anisometropia.

  (Chisholm SAM, Costakos DM, Harris GJ.) Ophthalmic Plast Reconstr Surg. 2019 Jul/Aug;35(4):374-377 PMID: 30789542 SCOPUS ID: 2-s2.0-85069292061 02/23/2019

• Herpes Zoster Ophthalmicus With Orbital Findings Preceding Skin Rash.

  (Chiang E, Bajric J, Harris GJ.) Ophthalmic Plast Reconstr Surg. 2018 Jul/Aug;34(4):e113-e115 PMID: 29634608 SCOPUS ID: 2-s2.0-85051074757 04/11/2018